Literature DB >> 9893030

Mycoplasma infection can sensitize host cells to apoptosis through contribution of apoptotic-like endonuclease(s).

I A Sokolova1, A T Vaughan, N N Khodarev.   

Abstract

Mycoplasma infection may lead to various pathologies in a broad range of hosts. It has been shown that Mycoplasma may trigger cell death in cell cultures; however, the mechanism remains unknown. In the present paper we show that Mycoplasma infection of different lymphocyte and epithelial tumour cell lines leads to the inhibition of proliferation, and increased cell death, accompanied by DNA fragmentation and the morphological features of apoptosis. We also showed that this infection leads to an increased sensitivity of cells to various inducers of apoptosis targeting different signalling pathways. Finally, we show that increased apoptosis is associated with overexpression of an endonuclease produced by Mycoplasma. This endonuclease is recovered in the nuclear fraction of host cells, introduces mostly DSB and is active at neutral pH in the presence of divalent cations. Activation of this endonuclease is connected with limited proteolysis, which may be reproduced in vitro by snake venom serine proteinase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9893030     DOI: 10.1046/j.1440-1711.1998.00781.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  15 in total

1.  Mycoplasma alligatoris infection promotes CD95 (FasR) expression and apoptosis of primary cardiac fibroblasts.

Authors:  M E Hunt; D R Brown
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

2.  Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant.

Authors:  M Bendjennat; A Blanchard; M Loutfi; L Montagnier; E Bahraoui
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  In vitro infection of bovine monocytes with Mycoplasma bovis delays apoptosis and suppresses production of gamma interferon and tumor necrosis factor alpha but not interleukin-10.

Authors:  Musa Mulongo; Tracy Prysliak; Erin Scruten; Scott Napper; Jose Perez-Casal
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

4.  Mycoplasma pneumoniae Mpn133 is a cytotoxic nuclease with a glutamic acid-, lysine- and serine-rich region essential for binding and internalization but not enzymatic activity.

Authors:  Sudha R Somarajan; Thirumalai R Kannan; Joel B Baseman
Journal:  Cell Microbiol       Date:  2010-12       Impact factor: 3.715

5.  Effect of mycoplasmas on apoptosis of 32D cells is species-dependent.

Authors:  Shimin Zhang; Shyh-Ching Lo
Journal:  Curr Microbiol       Date:  2007-05-05       Impact factor: 2.188

6.  Prevention and detection of Mycoplasma contamination in cell culture.

Authors:  Laleh Nikfarjam; Parvaneh Farzaneh
Journal:  Cell J       Date:  2011-12-22       Impact factor: 2.479

7.  Mycoplasma agalactiae MAG_5040 is a Mg2+-dependent, sugar-nonspecific SNase recognised by the host humoral response during natural infection.

Authors:  Carla Cacciotto; Maria Filippa Addis; Elisabetta Coradduzza; Laura Carcangiu; Anna Maria Nuvoli; Gessica Tore; Gian Mario Dore; Daniela Pagnozzi; Sergio Uzzau; Bernardo Chessa; Marco Pittau; Alberto Alberti
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

8.  Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants.

Authors:  Haitian Zhao; Ute Dreses-Werringloer; Peter Davies; Philippe Marambaud
Journal:  BMC Res Notes       Date:  2008-06-30

9.  Mitochondrial activities in human cultured skin fibroblasts contaminated by Mycoplasma hyorhinis.

Authors:  Niklas Darin; Norman Kadhom; Jean-Jacques Brière; Dominique Chretien; Cécile M Bébéar; Agnès Rötig; Arnold Munnich; Pierre Rustin
Journal:  BMC Biochem       Date:  2003-11-04       Impact factor: 4.059

10.  Normal and tumoral melanocytes exhibit q-Gaussian random search patterns.

Authors:  Priscila C A da Silva; Tiago V Rosembach; Anésia A Santos; Márcio S Rocha; Marcelo L Martins
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.